Literature DB >> 11709041

In vitro models of the intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative methods.

E Le Ferrec1, C Chesne, P Artusson, D Brayden, G Fabre, P Gires, F Guillou, M Rousset, W Rubas, M L Scarino.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11709041     DOI： 10.1177/026119290102900604

Source DB:  PubMed          Journal:  Altern Lab Anim        ISSN： 0261-1929            Impact factor:   1.303


× No keyword cloud information.
  38 in total

Review 1.  Microfabrication technologies for oral drug delivery.

Authors:  Shilpa Sant; Sarah L Tao; Omar Z Fisher; Qiaobing Xu; Nicholas A Peppas; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2011-12-04       Impact factor: 15.470

2.  Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.

Authors:  Richard A Graves; Grace A Ledet; Elena Y Glotser; Demaurian M Mitchner; Levon A Bostanian; Tarun K Mandal
Journal:  Eur J Pharm Sci       Date:  2015-04-28       Impact factor: 4.384

3.  An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products.

Authors:  Kinga Jaworska; Tomasz Huc; Marta Gawrys; Maksymilian Onyszkiewicz; Emilia Samborowska; Marcin Ufnal
Journal:  J Vis Exp       Date:  2018-10-20       Impact factor: 1.355

4.  The SRC family tyrosine kinase HCK and the ETS family transcription factors SPIB and EHF regulate transcytosis across a human follicle-associated epithelium model.

Authors:  Tsuneaki Asai; Sherie L Morrison
Journal:  J Biol Chem       Date:  2013-02-25       Impact factor: 5.157

Review 5.  TEER measurement techniques for in vitro barrier model systems.

Authors:  Balaji Srinivasan; Aditya Reddy Kolli; Mandy Brigitte Esch; Hasan Erbil Abaci; Michael L Shuler; James J Hickman
Journal:  J Lab Autom       Date:  2015-01-13

Review 6.  Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control?

Authors:  Francisca Araújo; Pedro Fonte; Hélder A Santos; Bruno Sarmento
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

7.  Nonsteroidal Anti-Inflammatory Drug-Induced Leaky Gut Modeled Using Polarized Monolayers of Primary Human Intestinal Epithelial Cells.

Authors:  Aadra P Bhatt; Dulan B Gunasekara; Jennifer Speer; Mark I Reed; Alexis N Peña; Bentley R Midkiff; Scott T Magness; Scott J Bultman; Nancy L Allbritton; Matthew R Redinbo
Journal:  ACS Infect Dis       Date:  2017-11-10       Impact factor: 5.084

8.  Differential effect of oxidative stress on intestinal apparent permeability of drugs transported by paracellular and transcellular route.

Authors:  Pankaj Dixit; Dinesh Kumar Jain; Jaypal Singh Rajpoot
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-06-21       Impact factor: 2.441

9.  Influence of the nanocomposite MgAl-HTlc on gastric absorption of drugs: in vitro and ex vivo studies.

Authors:  Luana Perioli; Pamela Mutascio; Cinzia Pagano
Journal:  Pharm Res       Date:  2012-08-23       Impact factor: 4.200

10.  Disruption of epithelial barrier by quorum-sensing N-3-(oxododecanoyl)-homoserine lactone is mediated by matrix metalloproteinases.

Authors:  Sung Yong Eum; Dima Jaraki; Luc Bertrand; Ibolya E András; Michal Toborek
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.